4.7 Article

Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 62, 期 20, 页码 9315-9330

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.9b01340

关键词

-

资金

  1. Conselleria de Cultura, EducaciOn e Ordenacion Universitaria of the Galician Government [ED431B2017/70]
  2. Centro Singular de InvestigaciOn de Galicia accreditation [ED431G/09]
  3. European Regional Development Fund (ERDF), the Swedish Research Council
  4. Swedish strategic research program eSSENCE
  5. European COST action ERNEST [CA 18133]

向作者/读者索取更多资源

We report the identification of two subsets of fluorinated nonxanthine A(2B) adenosine receptor antagonists. The novel derivatives explore the effect of fluorination at different positions of two pyrimidine-based scaffolds. The most interesting ligands combine excellent hA(2B) affinity (K-i < 15 nM) and remarkable subtype selectivity. The results of functional cAMP experiments confirmed the antagonistic behavior of representative ligands. The compounds were designed on the basis of previous molecular models of the stereoselective binding of the parent scaffolds to the hA(2B) receptor, and we herein provide refinement of such models with the fluorinated compounds, which allows the explanation of the spurious effects of the fluorination at the different positions explored. These models are importantly confirmed by a synergistic study combining chiral HPLC, circular dichroism, diastereoselective synthesis, molecular modeling, and X-ray crystallography, providing experimental evidence toward the stereospecific interaction between optimized trifluorinated stereoisomers and the hA(2B) receptor.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据